Merus Labs International (Merus Labs International) Total Current Assets : $34.98 Mil (As of Mar. 2017)

View and export this data going back to 1996. Start your Free Trial

What is Merus Labs International Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Merus Labs International's total current assets for the quarter that ended in Mar. 2017 was $34.98 Mil.

Merus Labs International Total Current Assets Historical Data

The historical data trend for Merus Labs International's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merus Labs International Total Current Assets Chart

Merus Labs International Annual Data

Trend

Sep07

Sep08

Sep09

Sep10

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Total Current Assets

Get a 7-Day Free Trial

13.35

16.15

19.47

46.98

34.19

Merus Labs International Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Total Current Assets	Get a 7-Day Free Trial															28.29	28.85	34.19	38.68	34.98

Merus Labs International Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Merus Labs International's Total Current Assets for the fiscal year that ended in Sep. 2016 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	2.454	+	21.816	+	9.689	+	0.231
	=	34.19

Merus Labs International's Total Current Assets for the quarter that ended in Mar. 2017 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	0.979	+	21.299	+	11.531	+	1.17
	=	34.98

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Merus Labs International (NAS:MSLI) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Merus Labs International's Liquidation Value for the quarter that ended in Mar. 2017 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.979	-	121.077	+	0.75 * 0	+	0.5 * 11.531
=	-114.33

Merus Labs International Total Current Assets Related Terms

Thank you for viewing the detailed overview of Merus Labs International's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Merus Labs International (Merus Labs International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merus Labs International Inc (NAS:MSLI) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.meruslabs.com

Merus Labs International Inc was incorporated on October 1, 2012 in British Columbia. The Company is a specialty pharmaceutical company. It acquires prescription medicines in various categories which include on patent but at maturity stage of product life cycle; branded generics; under promoted products; Niche market pharmaceuticals; and products with annual sales below critical threshold for large pharma. The Company competes with multinational pharmaceutical development corporations to small, single product companies that may limit their activities to a particular therapeutic area or region or territory.

Merus Labs International (Merus Labs International) Headlines

From GuruFocus

Update on Merus Labs International, Athabasca Minerals Inc, Enghouse Systems Limited, WiLAN Inc.

By Gordon Pape Gordon Pape • 06-22-2015

Slow Growth Ahead; Updates on Merus Labs International, Enghouse Systems, Athabasca Minerals

By Gordon Pape Gordon Pape • 10-05-2015

Merus Labs International: A Pharma Stock With Growth Potential

By Gordon Pape Gordon Pape • 03-30-2015